CANCERFORSKNINGSFONDET AF 1989 has a total of 17 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CANCERFORSKNINGSFONDEN AF 1989, DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS and D GEN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | Denmark | 2 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Microorganisms | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Ellis Vincent | 13 |
#2 | Pyke Charles | 11 |
#3 | Behrendt Niels | 10 |
#4 | Dano Keld | 9 |
#5 | Danoe Keld | 7 |
#6 | Ploug Michael | 6 |
#7 | Blasi Francesco | 6 |
#8 | Stephens Ross W | 6 |
#9 | Appella Ettore | 6 |
#10 | Salonen Eeva-Marjatta | 5 |
Publication | Filing date | Title |
---|---|---|
AU5187698A | Inhibition of invasive remodelling | |
JPH0859700A | Upa bonded part of domain 2+3 of upar and antibody | |
US5891664A | Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR) | |
DK85193D0 | Suppression of inhibitors | |
US5519120A | Urokinase-type plasminogen activator receptor antibodies | |
AU8757291A | Antibodies against the urokinase receptor and their use | |
DK251090D0 | Antibodies and use thereof | |
CA2051676A1 | Urokinase-type plasminogen activator receptor |